Rafferty Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Rafferty Asset Management, LLC
- $22.9 Billion
- Q1 2025
A detailed history of Rafferty Asset Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 421,529 shares of IOVA stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
421,529
Previous 554,141
23.93%
Holding current value
$1.11 Million
Previous $4.1 Million
65.78%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding IOVA
# of Institutions
321Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$73.3 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$64.5 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$56 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$33.6 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$29.1 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $417M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...